5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose structure
|
Common Name | 5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose | ||
|---|---|---|---|---|
| CAS Number | 503543-44-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose |
|---|
| Description | 5-O-Benzoyl-1,2,3-tri-O-acetyl-4-C-methyl-D-ribofuranose is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| InChIKey | SECVTQZASDRQMX-IGEHEEHSSA-N |
|---|---|
| SMILES | CC(=O)OC1OC(C)(COC(=O)c2ccccc2)C(OC(C)=O)C1OC(C)=O |